Breaking News Instant updates and real-time market news.

EQ

Equillium

$11.10

0.16 (1.46%)

08:22
12/19/18
12/19
08:22
12/19/18
08:22

Equillium receives fast track designation from FDA for EQ001

Equillium announced that the FDA has granted fast track designation for EQ001 for the treatment of acute graft-versus-host disease, or aGVHD. The company is planning to initiate a Phase 1b/2 clinical trial in early 2019, called the EQUATE trial, which will evaluate EQ001 for the treatment of patients presenting with aGVHD. The EQUATE trial is a Phase 1b/2 clinical trial that will enroll approximately 84 patients to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and clinical activity of EQ001 for the initial treatment of aGVHD in combination with corticosteroids. The Phase 1b component is an open-label dose escalation trial and will be followed by the Phase 2 component, which is a randomized, double-blind, placebo-controlled trial in which subjects will receive either EQ001 or placebo in combination with corticosteroids over a two-month period.

EQ Equillium
$11.10

0.16 (1.46%)

11/06/18
11/06/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Arcosa (ACA) initiated with a Buy at Gabelli. 2. Alder Biopharmaceuticals (ALDR) resumed with an Outperform at Wells Fargo. 3. Anaplan (PLAN) initiated with a Buy at Canaccord and Needham, an Overweight at Barclays and Piper Jaffray, an Outperform at JMP Securities, an In Line at Evercore ISI, an Equal Weight at Morgan Stanley, a Sector Weight at KeyBanc, and a Neutral at Goldman Sachs. 4. Equillium (EQ) initiated with a Buy at Stifel and Jefferies. 5. Badger Meter (BMI) initiated with a Buy at Maxim. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/06/18
JEFF
11/06/18
INITIATION
Target $19
JEFF
Buy
Equillium initiated with a Buy at Jefferies
Jefferies analyst Biren Amin started Equillium with a Buy rating and $19 price target. The company is taking three shots on goal with lead asset EQ001, which is being developed for acute graft-vs.-host disease, chronic GvHD, and non-eosinophilic asthma, Amin tells investors in a research note. He sees data readouts as having the potential to unlock further share value.
11/06/18
STFL
11/06/18
INITIATION
Target $22
STFL
Buy
Equillium initiated with a Buy at Stifel
Stifel analyst Adam Walsh initiated Equillium with a Buy rating and $22 price target, citing the potential for lead asset EQ001. While noting a lack of near-term readouts, Walsh points to the selection of a fourth indication for EQ001 in the first half of 2019 and potential Phase 1b/2 interim aGVHD data in the second half of next year as "the first movers of shares."

TODAY'S FREE FLY STORIES

KNX

Knight-Swift

$35.47

-0.575 (-1.60%)

10:08
10/15/19
10/15
10:08
10/15/19
10:08
Recommendations
Knight-Swift analyst commentary  »

Knight-Swift guidance cut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

C

Citi

$69.90

-0.38 (-0.54%)

10:07
10/15/19
10/15
10:07
10/15/19
10:07
Hot Stocks
Citi says environment is 'highly unpredictable,' waters 'choppy' »

CEO Mike Corbat says the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 12

    Nov

10:07
10/15/19
10/15
10:07
10/15/19
10:07
Conference/Events
JPMorgan agricultural/machinery analyst holds analyst/industry conference call »

Machinery Equity Analyst…

TLRY

Tilray

$22.00

1.35 (6.54%)

10:05
10/15/19
10/15
10:05
10/15/19
10:05
Options
Tilray call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

TNDM

TNDM

, ABT

Abbott

$81.63

1.82 (2.28%)

10:00
10/15/19
10/15
10:00
10/15/19
10:00
Recommendations
TNDM, Abbott, DexCom analyst commentary  »

Tandem, Abbott agreement…

TNDM

TNDM

ABT

Abbott

$81.63

1.82 (2.28%)

DXCM

DexCom

$147.49

-12.71 (-7.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 04

    Nov

  • 06

    Nov

  • 13

    Nov

  • 14

    Nov

GM

General Motors

$35.28

-0.23 (-0.65%)

10:00
10/15/19
10/15
10:00
10/15/19
10:00
Periodicals
Breaking Periodicals news story on General Motors »

GM near agreement with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

UNH

UnitedHealth

$233.77

13.45 (6.10%)

10:00
10/15/19
10/15
10:00
10/15/19
10:00
Hot Stocks
UnitedHealth rises 5.9% »

UnitedHealth is up 5.9%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

DS

Drive Shack

$4.01

0.28 (7.51%)

10:00
10/15/19
10/15
10:00
10/15/19
10:00
Hot Stocks
Drive Shack rises 7.0% »

Drive Shack is up 7.0%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APHA

Aphria

$5.26

0.93 (21.48%)

10:00
10/15/19
10/15
10:00
10/15/19
10:00
Hot Stocks
Aphria rises 20.9% »

Aphria is up 20.9%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 12

    Nov

WIT

Wipro

$3.76

0.07 (1.90%)

09:59
10/15/19
10/15
09:59
10/15/19
09:59
Earnings
Wipro sees Q3 IT Services business revenue $2.065B-$2.106B »

For the quarter ending…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

WIT

Wipro

$3.76

0.07 (1.90%)

09:57
10/15/19
10/15
09:57
10/15/19
09:57
Earnings
Wipro reports Q2 EPS 6c, consensus 6c »

Reports Q2 revenue $2.1B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

UNH

UnitedHealth

$233.50

13.18 (5.98%)

, ANTM

Anthem

$244.77

10.04 (4.28%)

09:55
10/15/19
10/15
09:55
10/15/19
09:55
Options
Early notable gainers among liquid option names on October 15th »

Notable gainers among…

UNH

UnitedHealth

$233.50

13.18 (5.98%)

ANTM

Anthem

$244.77

10.04 (4.28%)

CI

Cigna

$157.49

5.875 (3.87%)

SCHW

Charles Schwab

$38.63

0.89 (2.36%)

NVDA

Nvidia

$192.32

5.81 (3.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 18

    Oct

  • 23

    Oct

  • 27

    Oct

  • 31

    Oct

  • 20

    Nov

EMR

Emerson

$66.89

-0.32 (-0.48%)

09:54
10/15/19
10/15
09:54
10/15/19
09:54
Hot Stocks
D. E. Shaw sees 50% upside in Emerson shares, calls for cost cuts and split »

D. E. Shaw Group, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

JNJ

Johnson & Johnson

$132.66

1.99 (1.52%)

09:53
10/15/19
10/15
09:53
10/15/19
09:53
Hot Stocks
Breaking Hot Stocks news story on Johnson & Johnson »

Johnson & Johnson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

EMR

Emerson

$67.03

-0.18 (-0.27%)

09:51
10/15/19
10/15
09:51
10/15/19
09:51
Hot Stocks
Breaking Hot Stocks news story on Emerson »

D.E. Shaw calls for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

TNDM

TNDM

, ABT

Abbott

$81.63

1.82 (2.28%)

09:50
10/15/19
10/15
09:50
10/15/19
09:50
Recommendations
TNDM, Abbott, DexCom, Insulet analyst commentary  »

Abbott partnership a…

TNDM

TNDM

ABT

Abbott

$81.63

1.82 (2.28%)

DXCM

DexCom

$153.56

-6.64 (-4.14%)

PODD

Insulet

$154.02

1.72 (1.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 04

    Nov

  • 05

    Nov

  • 06

    Nov

  • 13

    Nov

  • 14

    Nov

AMBA

Ambarella

$56.30

3.19 (6.01%)

09:50
10/15/19
10/15
09:50
10/15/19
09:50
Recommendations
Ambarella analyst commentary  »

KeyBanc boosts Ambarella…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

09:50
10/15/19
10/15
09:50
10/15/19
09:50
General news
IMF's global growth outlooks were trimmed »

IMF's global growth…

NR

Newpark Resources

$6.77

-0.155 (-2.24%)

09:47
10/15/19
10/15
09:47
10/15/19
09:47
Hot Stocks
Newpark Resources falls -5.3% »

Newpark Resources is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

MTW

Manitowoc

$10.71

-0.68 (-5.97%)

09:47
10/15/19
10/15
09:47
10/15/19
09:47
Hot Stocks
Manitowoc falls -5.9% »

Manitowoc is down -5.9%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAGS

PagSeguro Digital

$40.25

-6 (-12.97%)

09:47
10/15/19
10/15
09:47
10/15/19
09:47
Hot Stocks
PagSeguro Digital falls -13.7% »

PagSeguro Digital is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

  • 17

    Dec

  • 17

    Oct

UNH

UnitedHealth

$233.30

12.98 (5.89%)

09:47
10/15/19
10/15
09:47
10/15/19
09:47
Hot Stocks
UnitedHealth rises 5.7% »

UnitedHealth is up 5.7%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

FRC

First Republic

$103.44

6.08 (6.24%)

09:47
10/15/19
10/15
09:47
10/15/19
09:47
Hot Stocks
First Republic rises 6.0% »

First Republic is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

APHA

Aphria

$5.39

1.06 (24.48%)

09:47
10/15/19
10/15
09:47
10/15/19
09:47
Hot Stocks
Aphria rises 21.8% »

Aphria is up 21.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 12

    Nov

TBPH

Theravance Biopharma

$17.25

(0.00%)

09:45
10/15/19
10/15
09:45
10/15/19
09:45
Syndicate
Theravance Biopharma 5.7M share Block Trade priced at $17.50 »

Woodford Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.